{"disease":{"id":"hepatomegaly","name":"hepatomegaly"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03666117","title":"Prevalence of Hepatomegaly in Children and Adolescents With Type 1 Diabetes Mellitus","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT03499808","title":"S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"SWOG Cancer Research Network","has_results":true},{"nct_id":"NCT03801434","title":"Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"William Shomali","has_results":false},{"nct_id":"NCT02421354","title":"Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true},{"nct_id":"NCT02298699","title":"Biomarker for Sly Disease (MPS VII) (BioSly)","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"CENTOGENE GmbH Rostock","has_results":false},{"nct_id":"NCT01331642","title":"Biomarker for Gaucher Disease: BioGaucher (BioGaucher)","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"CENTOGENE GmbH Rostock","has_results":false},{"nct_id":"NCT02298634","title":"Biomarker for Farber Disease (BioFarber)","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"CENTOGENE GmbH Rostock","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}